In a pressing call to action, the Canadian Cancer Society is urging provinces and territories to lower the colorectal cancer screening age from 50 to 45. This recommendation comes on the heels of alarming trends indicating that more individuals under 50 are being diagnosed with this disease compared to previous generations. The society’s advocacy stems from the case of Michael Groves, whose late-stage diagnosis exemplifies the urgent need for earlier detection measures.
A Personal Journey Through Cancer Diagnosis
Michael Groves, a resident of Ottawa, initially sought medical attention in January 2021, suspecting appendicitis due to persistent abdominal pain. After a series of evaluations ruled out this condition, Groves returned home, only to later observe blood in his stool. Although the symptoms subsided, his family doctor prudently recommended a colonoscopy for the following April.
“The thought that it could be colon cancer never crossed my mind,” Groves reflected. However, during the procedure, doctors discovered a five-centimetre tumour. Groves was diagnosed with Stage 3 colorectal cancer, which had already metastasised to two lymph nodes.
“The shock was just, like, wow, just devastating,” he recounted, noting that he had felt perfectly healthy prior to this revelation. Just days before his diagnosis, he had completed a 5K run, feeling energetic and fit.
Rising Incidence of Colorectal Cancer
Now aged 54, Groves passionately believes that if routine screening had been available for those in their 40s, his cancer could have been detected much earlier, potentially alleviating the extensive treatment he endured. He is far from alone in this belief; the Canadian Cancer Society has reported a concerning rise in colorectal cancer cases among individuals under 50, prompting their call for a policy change.
According to Brandon Purcell, the society’s advocacy manager for prevention and early detection, “People under 50 are two to 2.5 times more likely to be diagnosed with colorectal cancer than they were in previous generations. That growth is something that’s very concerning for us, and we think it’s time for governments to react to that so that we can catch more of these cancers early.”
The Importance of Routine Screening
Currently, individuals aged 50 and older in Canada undergo routine screening through a home-based fecal immunochemical test (FIT), which involves collecting a stool sample that is sent to a laboratory for analysis. A positive result prompts a follow-up colonoscopy to investigate the presence of cancer. Those under 50 with certain risk factors or symptoms, such as a family history of colorectal cancer or visible blood in their stool, may be referred for proactive colonoscopies.
However, experts argue that extending this screening to include those aged 45 and above could significantly enhance early detection rates. The Canadian Cancer Society suggests that early identification can yield survival rates as high as 90%. In contrast, the likelihood of survival drops dramatically to below 15% for cancers diagnosed at advanced stages.
In addition to detecting tumours, colonoscopies are also effective in identifying and removing precancerous polyps before they develop into cancer, a process that typically takes eight to ten years. Barry Stein, CEO of Colorectal Cancer Canada, echoes this sentiment and supports the initiative to begin routine screenings at age 45.
Evidence Supporting the Call to Action
Recent research adds weight to the argument for lowering the screening age. A modelling study published on March 7 in the Journal of the Canadian Association of Gastroenterology posits that starting FIT tests at age 45 could prevent approximately 15,070 colorectal cancer cases and 6,100 deaths over the next 45 years. Furthermore, the study estimates a cost savings of $233 million in cancer treatments, even accounting for the expenses associated with increased screenings and colonoscopies.
As the Canadian Cancer Society and Colorectal Cancer Canada continue to push for policy reform, the evidence increasingly supports the need for a proactive approach to colorectal cancer screening.
Why it Matters
The stakes could not be higher. With colorectal cancer cases on the rise among younger populations, timely intervention through routine screening could mean the difference between life and death. As Michael Groves’ story illustrates, early detection is crucial in improving outcomes and reducing the burden of treatment. By lowering the screening age, Canada has the opportunity to enhance public health strategies, save lives, and ultimately reduce healthcare costs associated with late-stage cancer treatments. The time for change is now.
